Potential for directing appropriate responses to vaccines by cytokine manipulation

Clinical Immunotherapeutics

Volumn 5, Issue 5, 1996, Pages 327-333

  Tang, Yi Wei ^a   Graham, Barney S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ANTIGEN; CYTOKINE; VACCINE;

ANIMAL EXPERIMENT; CELLULAR IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0029890102     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259330     Document Type: Review

References (77)

1. Mosmann TR. Cherwinski H, Bond MW. el al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Inmnmol 1986; 136: 2348-57
2. Mosmann TR. Coftman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Imniunol 1989; 7: 145-73
3. Street NE. Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB j'l991;5: 171-7
4. Stevens TL. Bossie A. Sanders VM. et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988; 334: 255-8
5. Finkclmun FD. Holmes J. Katona I. et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990: 8: 303-33
6. Del Prête GF. De Carli M. Mastromauro C. et al. Purified protein derivative ol Mn'ohtictei'htni litberciilosis and excretorysecretory antigen(s) of T<>.\ocai'n cuuif, expand in vitro human T cells with stable and opposite (type l T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991: 88: 346-50
7. Romagnani S. Human THI and TH2 subsets: doubt no more. Immunol Today 1991; 12: 256-7
8. Yssel H, Shanafelt MC, Soderherg C. et al. Borrelta hurgjorferi activates a T helper type I-I ike T cell subset in Lyme arthritis. J ExpMed 1991; 174:593-601
9. Yamamura M. Uyemtira K. Deans RJ. et al. Defining protectiveresponses to pathogens: cytokine profiles in leprosy lesions. Science 1991:254: 277-9
10. Erard F. Wild M-T. Garcia-Sanz JA. et al. Sw itch o! CD8 T cells to noncytolytic CD8-CD4- cells that make Th2 cytokines and help B cells. Science 1993: 260: 1802-5
11. Croft M. Carter L. Swain SL. et al. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-I2 in promoting type 2 versus type I cytokine profiles. J Exp Med 1994: 180:'l 715-28
12. Cronin IX' II. Stack R. Filch FW. IL-4-producing CD8+ T cell clones can provide B cell help. J Immunol 1995; 154:3118-27
13. Ferrick DA. Schrenzel MD. MulvaniaT. et al. Differential production of interferon-gamma and interleukin-4 in response to Thl- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995; 373: 255-7
14. Scharton TM, Scott P. Natural killer cells are a source of Interferon gamma thai drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. JExpMed 1993; 178:567-77
15. Doherty TM, Coffman RL. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. 1 Immunol 1993: 150: 5476-83
16. Hsieh CS. Macatonia SE, Tripp CS, et al. Development of TH1 CD4+ T cells through IL-12 produced by LJ.vfe/ra-induced macrophages. Science 1993; 260: 547-9
17. Scott P, Natovitz P. Sher A. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. J Immunol 1986; 137: 1017-21
18. Shankar AH, Titus RG. T ceil and non-T cell compartments can independently determine resistance to Leishmania major. J ExpMed 1995; 181: 845-55
19. Clerici M, Sarin A, Coffman RL, et al. Type I/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sei USA 1994; 91: 11811-5
20. Sadick MD, Locksley RM, Tubbs C, et al. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J Immunol 1986; 1.36: 655-61
21. Heinzel FP, Sadick MD, Holaday BJ, et al. Reciprocal expression of Interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989: 169:59-72
22. Buchmeier NA, Schreiber RD. Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sei USA 1985; 82: 7404-8
23. Gazzinelli RT. Hakim FT, Hieny S, et al. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 1991; 146: 286-92
24. Sher A, Coffman RL, Hieny S, étal. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosnma mansani in the mouse. J Immunol 1990; 145:3911-6
25. Romani L, Mocci S, Bietta C, et al. Thl and Th2 cytokine secretion patterns in murine candidiasis: association of Thl responses with acquired resistance. Infect Immun I99I; 59: 4647-54
26. Leiby DA. Fortier AH, Crawt'ord RM. et al. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun 1992; 60: 84-9
27. Huygen K, Abramowicz D, Vandenbussche P, et al. Spleen cell cytokine secretion in M\cobacterittm hovis BCG-infected mice. Infect Immun 1992; 60: 2880-6
28. Graham BS, Henderson GS, Tang YW, et al. Priming immunization determines T helper cytokine mRNA expression palterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993; 151: 2032-40
29. Alwan WH, Kozlowska WJ, Openshaw PJ. Distinct types of lung disease caused by functional subsets of antiviral T cells. JExpMed 1994; 179: 81-9
30. Kanagawa O, Vaupel BA, Gayama S, et al. Resistance of mice deficient in 1L-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 1993; 262: 240-2
31. Graham MB, Braciale VL, BracialeTJ. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med 1994; 180: 1273-82
32. Zwingenberger K, Harms G, Pedrosa C, et al. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferongamma production. Clin Immunol Immunopathol 1990; 57: 242-9
33. Sanchez FO, Rodriguez Jl. Agudelo G, et al. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 1994; 62: 5673-8
34. Salgame P, Abrams JS. Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CDS T cell clones. Science 1991; 254: 279-81
35. Clerici M. Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91:759-65
36. Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis 1993; 168: 275-81
37. Katona IM. Urban Jr JF, Finkelman FD. The role of L3T4+ and Lyt-2+ T cells in the IgE response and immunity to Nippo.ttmngylus hra.iilien.tis. J Immunol 1988; 140: 3206-11
38. Urban Jr JF, Katona IM, Paul WE, et al. Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc Natl Acad Sei USA 1991; 88: 5513-7
39. Korenaga M, Hitoshi Y, Yamaguchi N, et al. The role of interleukin-5 in protective immunity to Stmngyloides venezuelen.51.5 infection in mice. Immunology 1991; 72: 502-7
40. Else KJ, Finkelman FD, Maliszewski CR, et al. Cytokinemediated regulation of chronic intestinal helminth infection. J Exp Med 1994; 179: 347-51
41. Bancroft AJ, Grencis RK, Else KJ, et al. The role of CD4 cells in protective immunity to Brugiu puhangi. Parasite Immunol 1994; 16: 385-7
42. Kennedy MK, Torrance DS, Picha KS, et al. Analysis of cytokine mRN A expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992; 149:2496-505
43. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental allergic encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of TGF-, IL-4, and prostaglandin E expression in the brain. J Exp Med 1992; 176: 1355-64
44. Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Thl/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995:80:707-18
45. Matyniak JE, Reiner SL. T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 1995: 181: 1251-4
46. Liblau RS, Singer SM, McDevitt HO. Thl and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16: 34-8
47. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sei USA 1994; 91: 8562-6
48. Ungar BL, Kao TC, Burris JA, et al. CrypJosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. J Immunol 1991; 147: 1014-22
49. Taylor-Robinson AW. Phillips RS. Severn A. el ul. The role of THI and TH2 cells in a rodent malaria infection. Science 1943: 26: 1931-4
50. Spinella S. Milon G. Hontebeyrie-Joskowicz M. A CD4+ TH2 cell line isolated from mice chronically infected with Tiyptino\onui cruzi induces IgG2 polyclonal response in vivo. Bur J Immunol 1990:20: 1045-51
51. I. Hsieh CS. Hcimberger AB. Gold JS. et al. Differential regulation of T helper phenotype development by interleukin 4 and 10 in an alpha beta T cell-rcceplor Iransgenic system. Proc Nail Acad Sei USA 1992: 89: 6065-9
52. Scdar RA. Paul WE. Davis MM. et al. The presence of inter leukin-4 during in vitro priming determines the lymphokineproducing potential of CD4+ T cells from T cell receptor Iransgenic mice. J Exp Med 1992: 176: 1091-8
53. Slaruch MJ, Wood DD. The adjuvanticily of interleukin I in vivo. J Immunol 1983: 130: 2191-4
54. Playfair JHL. DeSouza .IB. Recombinant gamma interferon is potent adjuvant fora malaria vaccine in mice..I Clin Immunol 1987:67:5-10
55. Dranoff G. Jaffee E, Lazenby A, et al. Vaccination with irradiated lumor cells engineered to secrete murine granulocytemacrophage colony-stimulating factor stimulates potent, specific, and Iong4asting anti-tumor immunity. Proc Natl Acad Sei USA 1993: 90: 3539-43
56. Tao MH. Levy R. Idiotype/granulocvte-macrophage colonystimulating factor fusion protein as a vaccine for B-cell lyinphoma. Nature 1993; 362: 755-8
57. Afonso LC. Seharton TM. Vieira LO. et al. The adjuvant effect of interleukin-12 in a vaccine against Lt'i\liincinia nitijor. Science 1994:263:235-7
58. Ramsay AJ. Husband AJ. Ramshaw [A. et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994:264:561-3
59. Ramsay AJ. Kohoneu-Corish M. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur J Immunol 1993; 23: 3141-5
60. Wynn TA. Eltoum I. Oswald IP. et al. Endogenous interleukin 12 (IL 12) regulates granuloma formation induced by eggs of SclusltiHiitid iiKituoiu and exogenous II.-12 both inhibits and prophylactically immunizes against etzg pathology. J Exp Med 1994: 179:'1551-61
61. Tang YW. Graham BS. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syneytial virus. J Clin Invest 1994; 94: 1953-8
62. Tang YW. Graham BS. Interleukin 12 treatment during immunization elicits a Th I -like immune response in mice challenged with respiratory syneytial virus and improves vaccine immunogenicity. J Infect Dis 1995; 172: 734-8
63. Audibert FM. Lise Lu. Adjuvants: current status, clinical perspectives and future prospects. Trends Pharmacol Sei 1993: 14: 174-8
64. Qureshi N. Takayama K. Rihi E. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide öl'Siiluitinellti t\ï>hinntriti>ii. J Biol Chem 1982; 257: 11805-15
65. Tomai MA. Johnson AG. T cell and imert'eron-gamma involvement in Ihe adjuvant action of a detoxified endotoxin. J Biol Response Mod 1989; 8: 625-41
66. Takayama K. Olsen M. Dalla P. et al. Adjuvant activity of nonionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides. lipid A and precursors. Vaccine 1991; 9:257-65'
67. Kensil CR. Patel I1. I.ennick M. et al. Separation and characterization of saponins with adjuvant activity from Quilliiju iiipimariii Molina corlex. J Immunol 1991: 146:431-7
68. Jones PD. Tha Hla R. Morein B. et al. Cellular immune responses in the murine lung to local immuniJ.ation xvilh influenJ.a A virus glycoproteins in micelles and iminunostimulatorv complexes Iiscoms). Scand J Immunol I98X; 27: 645-52
69. Takehashi H. Takeshita T. Morein B. el al. Induction of CD8+ cytoloxic T cells by immunization with purified HIV-1 envelop protein in ISCOMs. Nature 1990: 344: 873-5
70. Overnes G. Nesse LL. Waideland H. et al. Immune response after immuniJ.ation with an experimental Tomplasmu #<;
71. Newman MJ. Wu JY. Gardner BH. et al. Saponin adjuvant induction of ovalbumin-specific CD8+ cylotoxic T lymphocyte responses. J Immunol 1992: 148: 2357-62
72. Ramshaw 1A. Andrew ME. Phillips SM, et al. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Nature 1987; 329: 545-6
73. Taylor J. Trimarchi C. Weinberg R. et al. Efficacy studies on canarypox-rabies recombinant virus. Vaccine 1991; 9: 190-6
74. Leong KH. Ramsay AJ, Boyle DB. et al. Selective induction of immune responses by cytokines coexpres.sed in recombinanl towlpox \irus. J Virol 1994: 68: 8125-30
75. Ulmer JB. Donnell) JJ. Parker SE, et al. Heterologous protection against influen/a by injection of DNA encoding a viral protein. Science 1993: 259: 1745-9
76. Robinson Hi,. Hunt LA. Webster RG. Protection against a lethal influen/a virus challenge by immunl/ation with a haemagglulinin-expressing plasmid DNA. Vaccine 1993; 11: 957-60
77. Collins PL. Mink MA. Stec DS. Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene. Proc Nail Acad Sei l'S A 1991; 88: 9663-7